Twinrab 1500Iu/2.5Ml Inj Substitute


Composition:
DOCARAVIMAB-300IU + MIROMAVIMAB-300IU
Uses:
<p>Twinrab 1500Iu/2.5Ml Inj is used in post-exposure rabies prevention. The detailed uses of Twinrab 1500Iu/2.5Ml Inj are as follows:</p><ul><li><strong>Prevention of post-exposure rabies:</strong> Twinrab 1500Iu/2.5Ml Inj is used for post-exposure rabies prevention.</li><li><strong>Prevents clinical symptoms:</strong> Twinrab 1500Iu/2.5Ml Inj helps prevent clinical symptoms and fatal progression of rabies.</li></ul>
Medicinal Benefits:
Twinrab 1500Iu/2.5Ml Inj is a combination medicine belonging to the monoclonal antibody class. It is used in post-exposure rabies prophylaxis (prevention). Twinrab 1500Iu/2.5Ml Inj contains Docaravimab and Miromavimab, which bind to the rabies virus and neutralize it, providing immediate passive immunity to individuals exposed to it.
Twinrab 1500Iu/2.5Ml Inj is used in post-exposure rabies prophylaxis (prevention).
Twinrab 1500Iu/2.5Ml Inj contains Docaravimab and miromavimab as its active components. It works by binding to the rabies virus and neutralizing it, providing immediate passive immunity to individuals exposed to the virus.
Twinrab 1500Iu/2.5Ml Inj causes side effects such as injection site reactions like pain, redness, swelling, and low-grade fever. Therefore, contact a doctor if these side effects persist or worsen.
No, Twinrab 1500Iu/2.5Ml Inj is not habit-forming. You are advised to talk to a doctor before completely stopping the treatment regimen or if you have any concerns.
Twinrab 1500Iu/2.5Ml Inj is stored in temperatures between 2°C and 8°C. Protect from light. Do not freeze. Keep out of reach of children.
Twinrab 1500Iu/2.5Ml Inj is a parenteral therapy, administered by a healthcare professional. The appropriate dose is carefully determined and given based on individual patient needs. Using more than the recommended dose is not recommended, as it can increase the risk of serious side effects.